C.Q. Pharmaceutical Holding announcement, the board of directors received the written resignation report from the company's securities affairs representative Cao Fang on November 4, 2024. Due to job transfer reasons, Cao Fang applied to resign from the position of head (director) of the company's securities department (board office) and the company's securities affairs representative. After resignation, Cao Fang will no longer hold any positions in the company or its subsidiaries. His resignation will not affect the normal operation of relevant work in the company. As of the date of this announcement, Cao Fang does not hold any company shares. The company and the board of directors express sincere thanks to Cao Fang for his contributions during his tenure.